Barry Griffiths

Barry Griffiths is the CEO of New Zealand Sleep, focusing on testing and solutions for sleep apnoea. He acknowledges the availability of melatonin as a positive development but warns that its use could exacerbate breathing issues for individuals with sleep apnoea, leading to disrupted sleep patterns despite potential benefits in duration.